Orascom Construction PLC (EGX:ORAS)

Lumos Pharma Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	42,713	34,407	11,081	11,537	9,168	9,576
Market Cap Growth	9.55%	210.51%	-3.95%	25.84%	-4.26%	-16.23%
Enterprise Value	11,166	15,529	6,609	10,249	7,843	7,218
Last Close Price	390.00	273.24	161.86	77.64	54.36	55.15
PE Ratio	8.71	5.74	2.26	4.11	5.15	6.69
PS Ratio	0.25	0.21	0.11	0.11	0.17	0.18
PB Ratio	1.24	1.05	0.50	0.67	0.85	0.95
P/TBV Ratio	1.35	1.14	0.54	0.75	0.94	1.05
P/FCF Ratio	3.04	1.19	1.96	3.22	4.25	6.37
P/OCF Ratio	2.37	1.05	1.65	2.40	2.90	4.40
EV/Sales Ratio	0.07	0.09	0.06	0.10	0.14	0.14
EV/EBITDA Ratio	1.13	2.02	1.81	2.15	2.55	2.34
EV/EBIT Ratio	1.33	2.54	2.29	2.69	3.27	3.08
EV/FCF Ratio	0.79	0.54	1.17	2.86	3.64	4.80
Debt / Equity Ratio	0.54	0.48	0.38	0.33	0.11	0.20
Debt / EBITDA Ratio	2.19	2.07	2.18	1.16	0.38	0.67
Debt / FCF Ratio	1.33	0.55	1.48	1.60	0.56	1.37
Asset Turnover	0.90	0.85	0.94	1.09	0.90	0.92
Inventory Turnover	13.95	12.27	12.49	13.81	10.74	10.49
Quick Ratio	0.94	0.93	0.93	0.92	0.91	0.91
Current Ratio	1.01	1.00	1.02	1.01	1.00	1.01
Return on Equity (ROE)	16.21%	19.69%	27.82%	19.46%	18.83%	15.82%
Return on Assets (ROA)	2.32%	1.97%	1.62%	2.52%	2.42%	2.55%
Return on Capital (ROIC)	8.75%	7.73%	6.13%	11.38%	12.42%	12.64%
Return on Capital Employed (ROCE)	18.30%	16.80%	12.30%	20.80%	20.60%	20.60%
Earnings Yield	11.48%	17.43%	44.27%	24.36%	19.42%	14.94%
FCF Yield	32.94%	84.22%	51.08%	31.04%	23.52%	15.70%
Dividend Yield	5.30%	-	7.45%	14.67%	13.36%	6.60%
Payout Ratio	47.73%	36.44%	32.72%	47.58%	45.15%	26.95%
Buyback Yield / Dilution	1.12%	2.49%	3.17%	-	-	-
Total Shareholder Return	6.42%	2.49%	10.62%	14.67%	13.36%	6.60%

Updated Nov 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.